Study acute toxicity of 4-(R-amino)-5-(thiophen-2-ylmethyl)-4H-1,2,4-triazole-3-thiol in vivo

Journal Title: Фармацевтичний журнал - Year 2016, Vol 2, Issue 2

Abstract

Typically, the system is already known are used as the core for a new substance, which have already proved themselves as potential drugs. So one of these is 1,2,4-triazole ring. The purpose was to study acute toxicity of 4-((R-iden)amino)-5-(thiophen-2-ylmethyl)-4H-1,2,4-triazole-3-thiols and identify possible patterns acute toxicity of the chemical structure of indicators derivatives. In the study of acute contact toxicity was used spreadsheet rapid method for Prozorovsky V. B. Analysis of the results of studies acute toxicity of 1,2,4-triazole derivatives showed that all substances are relate to the 4th class of toxicity according to K. K. Sidorov. Their toxicity is in the range 357 ± 28–1 250 ± 220 mg/kg. Introduction in a molecule 4-amino-5-(thiophene-2-ylmethyl)-4H-1,2,4-triazole-3-thiol nitrobenzylidene, dimethylaminobenzylidene, 2-chloro-6-fluorobenzylidene substituent leads to a reduction of acute toxicity to the 566–576 mg/kg. Replacement of 2-chloro-6-fluorobenzylidene radical in a molecule 4-((2-chloro-6-fluorobenzylidene)amino)-5-(thiophene-2-ylmethyl)-4H-1,2,4-triazole-3-thiol at 4-fluorobenzylidene, 3,4-difluorobenzylidene, 4-methoxybenzylidene, 3,5-dimethoxybenzylidene leads to further reduce toxicity. Introduction methyl radical in a molecule 4-(benzylidene)amino)-5-(thiophene-2-ylmethyl)-4H-1,2,4-triazole-3-thiol and 4-((4-fluorobenzylidene)amino)-5-(thiophene-2-ylmethyl)-4H-1,2,4-triazole-3-thiol resulting to increased toxicity. It was established that the most toxic substance among the test compounds is 4-amino-5-(thiophen-2-ylmethyl)-4H-1,2,4-triazole-3-thiol. Its LD50 is 357 ± 28 mg/kg and the least toxic compound 4-((3,4-difluorbenzylidene)amino)-5-(thiophen-2-ilmethyl)-4H-1,2,4-triazole-3-thiol, LD50 1 250 ± 220 mg/kg.

Authors and Affiliations

A. A. Safonov

Keywords

Related Articles

Object and method of pharmaceutical law

The last time the questions of location of pharmaceutical right are acquired by more intent attention outside, both legists and organizers of фармации. Thus, actual is fundamental determinations of independence of such f...

Study of ointment base influence over biopharmaceutical characteristics of praziquantel semisolid dosage form for external use

Problem of acne dermatosis, complicated with demodicosis pharmacotherapy is one of the topical for the domestic dermatology because of a number of antidemodicosis medications isn’t large and almost all of the most effect...

Study of PEG-Filstim sub-acute toxicity

Febrile neutropenia caused by cytostatic therapy in the treatment of oncological diseases is a frequent complication, which results in enforced reduction in chemotherapy doses and lower effectiveness of the treatment. In...

Study of base influence on intensity of vinpocetine releasing from nasal soft dosage forms

At present pharmacotherapy is the main component in successful treatment of cerebrovascular pathology. Besides an arsenal of effective medications of conclusive medicine in this area is limited. The one of medications fo...

Effect of insoluble matrixformers on trimetazidine dihydrochloride in vitro release from matrix tablets

Oral matrix tablet is a modern dosage form using which could be achieved desirable in vitro dissolution profile of API and correspondent in vivo API concentration level. Therefore, the study of factors that affect in vit...

Download PDF file
  • EP ID EP563162
  • DOI 10.32352/0367-3057.2.16.06
  • Views 68
  • Downloads 0

How To Cite

A. A. Safonov (2016). Study acute toxicity of 4-(R-amino)-5-(thiophen-2-ylmethyl)-4H-1,2,4-triazole-3-thiol in vivo. Фармацевтичний журнал, 2(2), 98-101. https://europub.co.uk./articles/-A-563162